CoChat
Sign Up
Cited by 23

The DOI matches its Crossref record.

Peanut-Specific IgG4 and IgA in Saliva Are Modulated by Peanut Oral Immunotherapy

Smeekens, Johanna M., Baloh, Carolyn, Lim, Noha, Larson, David, Qin, Tielin, Wheatley, Lisa, Kim, Edwin H., Jones, Stacie M., Burks, A. Wesley, Kulis, Michael D.·2022·The Journal of Allergy and Clinical Immunology: In Practice
DOI 10.1016/j.jaip.2022.07.030PMC PMC9742136
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jaip.2022.07.030

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 24

  1. Lieberman, 2021, The global burden of illness of peanut allergy: a comprehensive literature review, Allergy, 76, 1367, 10.1111/all.14666 · DOI
  2. Jones, 2009, Clinical efficacy and immune regulation with peanut oral immunotherapy, J Allergy Clin Immunol, 124, 292, 10.1016/j.jaci.2009.05.022 · DOI
  3. Vickery, 2010, Individualized IgE-based dosing of egg oral immunotherapy and the development of tolerance, Ann Allergy Asthma Immunol, 105, 444, 10.1016/j.anai.2010.09.030 · DOI
  4. Vickery, 2018, AR101 oOral immunotherapy for peanut allergy, N Engl J Med, 379, 1991, 10.1056/NEJMoa1812856 · DOI
  5. Smeekens, 2020, Evolution of immune responses in food immunotherapy, Immunol Allergy Clin North Am, 40, 87, 10.1016/j.iac.2019.09.006 · DOI
  6. Patil, 2015, Peanut oral immunotherapy transiently expands circulating Ara h 2-specific B cells with a homologous repertoire in unrelated subjects, J Allergy Clin Immunol, 136, 125, 10.1016/j.jaci.2015.03.026 · DOI
  7. Burton, 2014, Oral immunotherapy induces IgG antibodies that act through FcgammaRIIb to suppress IgE-mediated hypersensitivity, J Allergy Clin Immunol, 134, 1310, 10.1016/j.jaci.2014.05.042 · DOI
  8. Varshney, 2011, A randomized controlled study of peanut oral immunotherapy: clinical desensitization and modulation of the allergic response, J Allergy Clin Immunol, 127, 654, 10.1016/j.jaci.2010.12.1111 · DOI
  9. Vickery, 2014, Sustained unresponsiveness to peanut in subjects who have completed peanut oral immunotherapy, J Allergy Clin Immunol, 133, 468, 10.1016/j.jaci.2013.11.007 · DOI
  10. Wood, 2016, Food allergen immunotherapy: current status and prospects for the future, J Allergy Clin Immunol, 137, 973, 10.1016/j.jaci.2016.01.001 · DOI
  11. Tordesillas, 2018, Mechanisms of oral tolerance, Clin Rev Allergy Immunol, 55, 107, 10.1007/s12016-018-8680-5 · DOI
  12. Du Toit, 2015, Randomized trial of peanut consumption in infants at risk for peanut allergy, N Engl J Med, 372, 803, 10.1056/NEJMoa1414850 · DOI · Paper page
  13. Konstantinou, 2014, Egg-white-specific IgA and IgA2 antibodies in egg-allergic children: is there a role in tolerance induction?, Pediatr Allergy Immunol, 25, 64, 10.1111/pai.12143 · DOI
  14. Orgel, 2019, Blocking antibodies induced by peanut oral and sublingual immunotherapy suppress basophil activation and are associated with sustained unresponsiveness, Clin Exp Allergy, 49, 461, 10.1111/cea.13305 · DOI
  15. Santos, 2015, IgG4 inhibits peanut-induced basophil and mast cell activation in peanut-tolerant children sensitized to peanut major allergens, J Allergy Clin Immunol, 135, 1249, 10.1016/j.jaci.2015.01.012 · DOI
  16. Jones, 2022, Efficacy and safety of oral immunotherapy in children aged 1–3 years with peanut allergy (the Immune Tolerance Network IMPACT trial): a randomised placebo-controlled study, Lancet, 399, 359, 10.1016/S0140-6736(21)02390-4 · DOI
  17. Bednar, 2018, Antigenic liposomes for generation of disease-specific antibodies, J Vis Exp, 140
  18. Externest, 2000, Correlations between antibody immune responses at different mucosal effector sites are controlled by antigen type and dosage, Infect Immun, 68, 3830, 10.1128/IAI.68.7.3830-3839.2000 · DOI
  19. Zhang, 2020, Divergent T follicular helper cell requirement for IgA and IgE production to peanut during allergic sensitization, Sci Immunol, 5, 10.1126/sciimmunol.aay2754 · DOI
  20. Kulis, 2012, Increased peanut-specific IgA levels in saliva correlate with food challenge outcomes after peanut sublingual immunotherapy, J Allergy Clin Immunol, 129, 1159, 10.1016/j.jaci.2011.11.045 · DOI
  21. Hansen, 2019, The inflammatory function of human IgA, Cell Mol Life Sci, 76, 1041, 10.1007/s00018-018-2976-8 · DOI · Paper page
  22. Tsai, 2020, Sustained successful peanut oral immunotherapy associated with low basophil activation and peanut-specific IgE, J Allergy Clin Immunol, 145, 885, 10.1016/j.jaci.2019.10.038 · DOI
  23. Patil, 2019, Early decrease in basophil sensitivity to Ara h 2 precedes sustained unresponsiveness after peanut oral immunotherapy, J Allergy Clin Immunol, 144, 1310, 10.1016/j.jaci.2019.07.028 · DOI
  24. Ruinemans-Koerts, 2022, The indirect basophil activation test is a safe, reliable, and accessible tool to diagnose a peanut allergy in children, J Allergy Clin Immunol Pract, 10, 1305, 10.1016/j.jaip.2021.12.040 · DOI

Cited by

Sorted by citations

See all 23

Metadata

Authors
Smeekens, J. M., Baloh, C., Lim, N., Larson, D., Qin, T., Wheatley, L., Kim, E. H., Jones, S. M., Burks, A. W., & Kulis, M. D.
Venue
The Journal of Allergy and Clinical Immunology: In Practice
Publisher
Elsevier BV
Published
2022-12
Volume
10
Issue
12
Pages
3270-3275
ISSN
2213-2198
DOI
10.1016/j.jaip.2022.07.030
PMC
PMC9742136
Cited by
23
References
0
Language
en
Licence
Funders
  • U.S. Department of Defense
  • Immune Tolerance Network
  • National Institute of Allergy and Infectious Diseases (UM1AI109565)
  • Aimmune Therapeutics
  • Genentech
  • Food Allergy Research and Education
  • National Institutes of Health (AI007062)
  • University of North Carolina Wilmington
  • Duke University

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Peanut-Specific IgG4 and IgA in Saliva Are Modulated by Peanut Oral Immunotherapy. https://app.cochat.ai/papers/10.1016/j.jaip.2022.07.030
The paper
Smeekens, J. M., Baloh, C., Lim, N., Larson, D., Qin, T., Wheatley, L., Kim, E. H., Jones, S. M., Burks, A. W., & Kulis, M. D. (2022). Peanut-Specific IgG4 and IgA in Saliva Are Modulated by Peanut Oral Immunotherapy. The Journal of Allergy and Clinical Immunology: In Practice. https://doi.org/10.1016/j.jaip.2022.07.030